Milestones

nova-satra-milestone-fundraised-2.8-million-v2

2017

S$2.8 million

fundraise

Announced the successful seed fundraise of S$2.8 million fully subscribed by Genting Biocellular Sdn. Bhd., a wholly owned subsidiary of Malaysia based conglomerate Genting Berhad.

nova-satra-milestone-completed-validation-trials-novotect

2016

Completed NovoTect™

Validation Trials

Completed validation trials for NovoTect™ Bc showing the upper range of test sensitivity is 83.3%, specificity 100% and positive predictive value 100%.

nova-satra-milestone-collaboration-with-university-of-oxford-v2

2015

Collaboration with

University of Oxford

Announced an exclusive collaboration and Asia licensing agreement for University of Oxford developed Epigenetic technology.